Research Topic · Peer-Reviewed

Lung Cancer

Lung cancer is a malignancy arising from the cells of the respiratory tract, most often the bronchial epithelium, and is broadly divided into non-small cell lung cancer, which includes adenocarcinoma and squamous cell carcinoma, and small cell lung cancer, which is more aggressive. Tumors develop when pulmonary cell…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 22× across the literature 🔖 ISSN 2689-5773 🗓 Reviewed July 2026

Overview

Lung cancer is a malignancy arising from the cells of the respiratory tract, most often the bronchial epithelium, and is broadly divided into non-small cell lung cancer, which includes adenocarcinoma and squamous cell carcinoma, and small cell lung cancer, which is more aggressive. Tumors develop when pulmonary cells proliferate uncontrollably, forming masses that can invade locally and metastasize to distant sites such as the adrenal glands and elsewhere. Tobacco exposure and other factors contribute to risk, and molecular characterization increasingly guides treatment. The articles assembled here address biology, prognosis, and therapy, including lung cancer with isolated adrenal metastases, the role of heparin in lung cancer, and a review of statins in relation to the disease. Treatment-oriented work includes cancer immunotherapy and the observation that immunotherapy use has not increased sublobar resections despite fewer pneumonectomies, reflecting evolving surgical and systemic strategies. Mechanistic and translational contributions examine solid tumor cell behavior in experimental systems and high-throughput disease modeling for biomarker development, while nutritional support for cancer-related cachexia addresses supportive care. Diagnosis combines imaging, pathology, and molecular testing, and staging directs the choice among surgery, radiation, and systemic therapy. Because lung cancer is often detected late and biologically diverse, early identification, accurate classification, and individualized, multidisciplinary treatment are central to improving outcomes.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2017

The Role of Heparin in Lung Cancer

Abu Arab WalidCorresponding author
Service de Chirurgie thoracique, Université de Sherbrooke, Québec, Canada
Exact topic Neoplasms Cited by 7 doi:10.14302/issn.2639-1716.jn-17-1499
2019

Avant Garde Alleviation -Cancer Immunotherapy

Bajaj AnubhaCorresponding author
MD. (Pathology) Panjab University, Department of Histopathology, A.B. Diagnostics, A-1, Ring Road , Rajouri Garden, New Delhi, 110027, India.
Exact topic Clinical and Diagnostic Pathology doi:10.14302/issn.2689-5773.jcdp-19-3061

How this research is being cited

The 12 articles above have been cited 22 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Lung Cancer, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Clinical and Diagnostic Pathology (ISSN 2689-5773).

Journal editorial board
Pietro Scicchitano · Italy Wael M. EL-Deeb · Saudi Arabia Bulent Uysal · United States

This page summarises published research for orientation; it is not medical or professional advice.